Summary
The 2024 Carrot IVF Outcomes Study presents an internal assessment of the clinical effectiveness of Carrot's fertility benefits program. The study tracked fertility outcomes of members enrolled in the program and compared these results against national data from the Society for Assisted Reproductive Technology (SART). Milliman, Inc. validated the measurement methodology used in the study, confirming that it aligns with industry practices. The findings indicate that Carrot members achieved a live birth rate of 55.4%, surpassing both the national average of 44.8% and the in-network average of 45.2%. Additionally, the study reports a miscarriage rate of 12.7% and a pregnancy rate of 67%. The report also highlights the low pre-term birth rate of 8.2% and the multiple birth rate of 1.8%, suggesting that Carrot's approach effectively balances high live birth rates with low risks of multiple births. Overall, the study underscores the effectiveness of Carrot's fertility care program.
